Core Insights - The company, Qianhai Health (00911), reported a mid-year revenue of approximately HKD 341 million for 2025, reflecting a year-on-year growth of 11.04% [1] - Despite the revenue increase, the net profit decreased to HKD 4.774 million, representing a significant decline of 69.3% compared to the previous period [1] - Earnings per share were reported at HKD 0.0282 [1] Financial Performance - Revenue for the mid-year period reached approximately HKD 341 million, marking an 11.04% increase year-on-year [1] - Gross profit fell from approximately HKD 42.9 million in the previous period to about HKD 14.2 million, indicating a substantial decline [1] - The decrease in gross profit is attributed to intensified market competition, which compelled the company to sell electronic components at lower profit margins [1]
前海健康公布中期业绩 净利477.4万港元 同比减少69.3%